Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Larochelle

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 7, 2000
Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertensionR D Feldman, N R Campbell, P Larochelle
Canadian Medical Association Journal|January 1, 1983
Comparison of chlorthalidone and spironolactone in low--renin essential hypertensionJ H Kreeft, P Larochelle, R I Ogilvie
Clinical Pharmacology and Therapeutics|May 1, 1981
Basis of false-positive glucagon tests for pheochromocytomaO Kuchel, P Hamet, N T Buu, et al.
Clinical Pharmacology and Therapeutics|April 1, 1985
Effect of metoclopramide on plasma catecholamine release in essential hypertensionO Kuchel, N T Buu, P Hamet, et al.
Life Sciences|February 15, 1982
Hypertension in hyperthyroidism: is there an epinephrine connection?O Kuchel, N T Buu, P Hamet, et al.
Journal of Pharmaceutical Sciences|June 1, 1980
GLC-mass spectrometric procedure with selected-ion monitoring for determination of plasma concentrations of unlabeled and labeled barbital following simultaneous oral and intravenous administrationF Varin, C Marchand, P Larochelle, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 20, 1999
Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of CanadaJ G Fodor, B Whitmore, F Leenen, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1990
Prolonged low dose infusion of atrial natriuretic factor in essential hypertensionJ R Cusson, G Thibault, M Cantin, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1988
Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in manJ A Sundsfjord, G Thibault, P Larochelle, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1980
Effect of acute and chronic administration of calcitonin on serum glucose in patients with Paget's disease of boneA Gattereau, P Bielmann, J Durivage, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 7, 2000
Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertensionR D Feldman, N R Campbell, P Larochelle
Canadian Medical Association Journal|January 1, 1983
Comparison of chlorthalidone and spironolactone in low--renin essential hypertensionJ H Kreeft, P Larochelle, R I Ogilvie
Clinical Pharmacology and Therapeutics|May 1, 1981
Basis of false-positive glucagon tests for pheochromocytomaO Kuchel, P Hamet, N T Buu, et al.
Clinical Pharmacology and Therapeutics|April 1, 1985
Effect of metoclopramide on plasma catecholamine release in essential hypertensionO Kuchel, N T Buu, P Hamet, et al.
Life Sciences|February 15, 1982
Hypertension in hyperthyroidism: is there an epinephrine connection?O Kuchel, N T Buu, P Hamet, et al.
Journal of Pharmaceutical Sciences|June 1, 1980
GLC-mass spectrometric procedure with selected-ion monitoring for determination of plasma concentrations of unlabeled and labeled barbital following simultaneous oral and intravenous administrationF Varin, C Marchand, P Larochelle, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 20, 1999
Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of CanadaJ G Fodor, B Whitmore, F Leenen, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1990
Prolonged low dose infusion of atrial natriuretic factor in essential hypertensionJ R Cusson, G Thibault, M Cantin, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1988
Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in manJ A Sundsfjord, G Thibault, P Larochelle, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1980
Effect of acute and chronic administration of calcitonin on serum glucose in patients with Paget's disease of boneA Gattereau, P Bielmann, J Durivage, et al.
Pageof 13